DXCM Dexcom PE ratio, current and historical analysis

As of Apr 2, 2025, the Dexcom stock's P/E ratio is 46.67. This takes into account the latest EPS of $1.46 and stock price of $68.14. The PE ratio has decreased by 23% from its last 4 quarters average of 60.5.

DXCM PE ratio history

How has DXCM's PE ratio performed in the past

The PE ratio of Dexcom has averaged 127.35 over the last seven years. The current price-to-earnings ratio of 46.67 is 63% less than the historical average. Analyzing the last seven years, DXCM's PE ratio reached its highest point in the Sep 2018 quarter at 298, when the price was $35.76 and the EPS was $0.12. The lowest point was recorded in the Sep 2024 quarter, when it reached 38.53 with a price of $67.04 and an EPS of $1.74.

Today
43.21
Average
127.35
Median
126.03
Minimum
38.53
Maximum
298

Dexcom PE ratio by year

Maximum annual increase: 278.63% in 2021

Maximum annual decrease: -67.58% in 2020

Year PE ratio PE change Price EPS
2024 53.27 -39.9% $77.77 $1.46
2023 88.64 -31.12% $124.09 $1.4
2022 128.68 -46.32% $113.24 $0.88
2021 239.71 278.63% $134.24 $0.56
2020 63.31 -67.58% $92.43 $1.46
2019 195.3 N/A $54.69 $0.28
2018 N/A N/A $29.95 -$0.36
2017 N/A N/A $14.35 -$0.15
2016 N/A N/A $14.93 -$0.2
2015 N/A N/A $20.48 -$0.18
2014 N/A N/A $13.76 -$0.08
2013 N/A N/A $8.85 -$0.11
2012 N/A N/A $3.4 -$0.2
2011 N/A N/A $2.33 -$0.17
2010 N/A N/A $3.41 -$0.24

Dexcom PE ratio by quarter (TTM)

Year PE ratio PE change Price EPS
Dec 2024 53.27 38.26% $77.77 $1.46
Sep 2024 38.53 -41.89% $67.04 $1.74
Jun 2024 66.3 -21.13% $113.38 $1.71
Mar 2024 84.06 -5.17% $138.7 $1.65
Dec 2023 88.64 -6.89% $124.09 $1.4
Sep 2023 95.2 -31.1% $93.3 $0.98
Jun 2023 138.18 -9.61% $128.51 $0.93
Mar 2023 152.87 18.8% $116.18 $0.76
Dec 2022 128.68 0.66% $113.24 $0.88
Sep 2022 127.84 2.91% $80.54 $0.63
Jun 2022 124.22 -34.93% $74.53 $0.6
Mar 2022 190.9 -20.36% $127.9 $0.67
Dec 2021 239.71 192.79% $134.24 $0.56
Sep 2021 81.87 25.01% $136.72 $1.67
Jun 2021 65.49 12.97% $106.75 $1.63

DXCM average PE ratio chart

What is the average PE ratio of DXCM for the past years

DXCM's current PE ratio is under its 3, 5 and 10-year averages.

3-year avg
99.8
5-year avg
112.85
10-year avg
127.35
15-year avg
127.35

DXCM PE vs peers

What is DXCM's PE ratio compared to its peers

DXCM's PE ratio is above its peer stocks JNJ and ABT. Dexcom's current PE ratio of 46.67 is more than the average of its peers, which is 25.3.

Stock name PE ratio Market cap
EW Edwards Lifesciences Corp 10.34 $42.41B
ABT Abbott Laboratories 17.4 $231.39B
MDT Medtronic plc 26.91 $114.25B
JNJ Johnson & Johnson 27.12 $381.26B
WST West Pharmaceutical Services Inc 32.55 $15.89B
BDX Becton Dickinson & Co 37.77 $64.63B
DXCM Dexcom Inc 43.21 $24.65B
TNDM Tandem Diabetes Care Inc N/A $1.2B
QDEL Quidel Corp N/A $2.24B

Frequently asked questions

What is Dexcom's PE ratio?

The price to earnings ratio for DXCM stock is 46.67 as of Apr 2, 2025.

What is the 3-year average PE ratio for Dexcom (DXCM)?

As an average over the last 3 years, DXCM stock has a PE ratio of 99.8.

What is the 5-year average PE ratio for Dexcom (DXCM)?

As an average over the last 5 years, DXCM stock has a PE ratio of 112.85.

What is the highest PE ratio for DXCM?

Over the last seven years, the quarterly PE ratio reached its highest level at 298 in the Sep 2018 quarter.

How does the current PE ratio for DXCM compare to its historical average?

DXCM's price to earnings ratio is currently 63% below its 7-year historical average.

How is DXCM's PE ratio calculated (Dexcom PE ratio formula)?

The P/E ratio is calculated by dividing the latest price of a stock by its trailing twelve months EPS. As of today (Apr 2, 2025), Dexcom's share price is $68.14. The company's earnings per share for the trailing twelve months (TTM) ending Dec 2024 is $1.46. Therefore, Dexcom's price to earnings ratio for today is 46.67. PE RATIO(46.67) = STOCK PRICE($68.14) / TTM EPS($1.46)

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.